Gawande’s Cheesecake Factory
Why Amazon, Berkshire Hathaway and J. P. Morgan picked Atul Gawande to revamp healthcare
Details about the healthcare organization Atul Gawande will run for Amazon.com Inc., Berkshire Hathaway Inc. and J. P. Morgan Chase & Co. are scarce -- basic facts, starting with its name, have not been disclosed. Still, enough information has been released to make educated guesses about its focus and possible impacts.
Based on his experience and the cultures of the three companies, Gawande’s first steps are likely to include using technology to change the way employees access care, trying to identify unnecessary or low-value care and looking for ways to standardize common procedures and treatments.
On June 20, America’s largest online retailer, the holding company and the financial services company announced they had hired Gawande as CEO of a new, non-profit company that will “address U.S. employee healthcare.”
Few healthcare pundits are as well known or widely respected. Gawande is a physician, biomedical researcher and founder of Ariadne Labs, a collaboration between Brigham and Women’s Hospital and Harvard University’s T.H. Chan School of Public Health that designs and helps implement improvements in healthcare delivery.
He is a prominent author who, by his own description,